Reported 125,000 shares, unchanged from the prior quarter.
Reported value 4.1%; share count 0.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2023-12-31 | 3511250 |
| 2024-03-31 | 4859200 |
| 2024-06-30 | 4219200 |
| 2024-09-30 | 4526400 |
| 2024-12-31 | 4081600 |
| 2025-03-31 | 0 |
| 2025-09-30 | 1764000 |
| 2025-12-31 | 2898000 |
| 2026-03-31 | 5996250 |
| 2026-06-30 | 7008750 |
| 2026-09-30 | 7295000 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Unchanged | 125,000 | 0 (0.0%) | 4.89% | $7,295,000 | 2026-11-12 | |
| Q2 2026 | Unchanged | 125,000 | 0 (0.0%) | 4.45% | $7,008,750 | 2026-08-13 | |
| Q1 2026 | Added | 125,000 | +50,000 (66.7%) | 5.01% | $5,996,250 | 2026-05-08 | |
| Q4 2025 | Added | 75,000 | +25,000 (50.0%) | 2.44% | $2,898,000 | 2026-02-02 | |
| Q3 2025 | New | 50,000 | +50,000 (0.0%) | 1.47% | $1,764,000 | 2025-11-13 | |
| Q1 2025 | Reduced | 0 | -160,000 (-100.0%) | 0 | $0 | 2025-05-09 | |
| Q4 2024 | Unchanged | 160,000 | 0 (0.0%) | 3.65% | $4,081,600 | 2025-02-07 | |
| Q3 2024 | Unchanged | 160,000 | 0 (0.0%) | 3.61% | $4,526,400 | 2024-11-12 | |
| Q2 2024 | Unchanged | 160,000 | 0 (0.0%) | 3.87% | $4,219,200 | 2024-08-01 | |
| Q1 2024 | Added | 160,000 | +35,000 (28.0%) | 4.08% | $4,859,200 | 2024-05-14 | |
| Q4 2023 | New | 125,000 | +125,000 (0.0%) | 2.82% | $3,511,250 | 2024-02-12 |
Who else reported the position
752 managers reported ROYALTY PHARMA PLC for Q3 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| MORGAN STANLEY | Reduced | 41,100,185 | -1,831,412 | 0.12% | $2,398,606,956 | 26 qtrs |
| Capital International Investors | Reduced | 33,897,019 | -1,376,751 | 0.41% | $1,978,230,029 | 6 qtrs |
| BlackRock Inc | Added | 29,117,396 | +1,284,419 | 0.03% | $1,699,291,230 | 9 qtrs |
| FMR LLC | Reduced | 19,348,880 | -5,164,934 | 0.05% | $1,129,200,661 | 26 qtrs |
| PRICE T ROWE ASSOCIATES INC MD | Added | 14,712,137 | +3,518,480 | 0.09% | $858,601,000 | 26 qtrs |
| STATE STREET CORPORATION | Added | 12,951,600 | +613,371 | 0.02% | $755,855,376 | 26 qtrs |
| Swedbank AB | Reduced | 10,260,593 | -466,015 | 0.51% | $598,808,207 | 22 qtrs |
| BAILLIE GIFFORD & CO | Reduced | 9,151,948 | -863,630 | 0.5% | $534,107,685 | 19 qtrs |
| Capital World Investors | Reduced | 8,755,768 | -761,569 | 0.06% | $510,986,620 | 3 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Added | 8,546,758 | +488,710 | 0.03% | $497,512,565 | 26 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- November 12, 2026
- Filing type
- 13F-HR
- Position type
- COM - CLASS A
Voting authority reported
- Sole
- 125,000
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.